One of the reasons for this dramatic, full-body response is that naloxone binds to opioid receptors all over the body, triggering involvement from organs like the skin and intestines, and not just ...
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...